Tesla
TSLA
Adobe
ADBE
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
US Stock MarketDetailed Quotes
BNTX BioNTech
- 97.050
- -3.590-3.57%
Close Mar 25 16:00 ET
- 97.200
- +0.150+0.15%
Pre 04:08 ET
23.29BMarket Cap-32.47P/E (TTM)
101.690High96.500Low552.25KVolume101.140Open100.640Pre Close54.27MTurnover0.60%Turnover RatioLossP/E (Static)239.97MShares131.49052wk High1.11P/B8.96BFloat Cap76.53052wk Low--Dividend TTM92.35MShs Float457.931Historical High--Div YieldTTM5.16%Amplitude12.361Historical Low98.262Avg Price1Lot Size
About BioNTech Company
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Company Profile
SymbolBNTX
Company NameBioNTech
Listing DateOct 10, 2019
Issue Price15.00
Founded2008
CEOProfessor Ugur Sahin, M.D.
MarketNASDAQ
Employees6772
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressAn der Goldgrube 12
CityMainz
ProvinceRheinland-Pfalz
CountryGermany
Zip Code55131
Phone49-6131-9084-0
Websitehttp://www.biontech.de
Company Executives
- Name
- Position
- Salary
- Professor Ugur Sahin, M.D.
- Chief Executive Officer
- 5.35M
- Annemarie Hanekamp
- Chief Commercial Officer
- 4.93M
- Ryan Richardson
- Chief Strategy Officer
- 2.56M
- Dr. Ozlem Tureci, M.D.
- Chief Medical Officer
- 2.53M
- James Ryan, PhD
- Chief Legal Officer and Chief Business Officer
- --
- Jens Holstein
- Chief Financial Officer
- 777.00K
- Dr. Sierk Poetting, PhD
- Chief Operating Officer
- 791.00K
- Helmut Jeggle
- Chairman of the Supervisory Board
- 288.00K
- Dr. Ulrich Wandschneider, PhD
- Deputy Chairman of the Supervisory Board
- 157.00K
- Michael Motschmann
- Member of the Supervisory Board
- 100.00K
- Baroness Nicola Blackwood
- Member of the Supervisory Board
- 100.00K
- Professor Rudolf Staudigl, PhD
- Member of the Supervisory Board
- 114.00K
- Professor Anja Morawietz, PhD
- Member of the Supervisory Board
- 130.00K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
